05/15/2026 | Press release | Distributed by Public on 05/15/2026 15:02
| AS REPORTED | PRO FORMA | |||||||||||||||||||
| March 31, 2026 | Debt Conversion | Series D Issuance | March 31, 2026 | |||||||||||||||||
| ASSETS | ||||||||||||||||||||
| CURRENT ASSETS: | ||||||||||||||||||||
| Cash | $ | 25,497 | $ | - | $ | 30,000 | $ | 55,497 | ||||||||||||
| Restricted cash | 605 | - | - | 605 | ||||||||||||||||
|
Health plan receivable, net of allowance for credit losses of $281
|
124,894 | - | - | 124,894 | ||||||||||||||||
| Clinic fees, insurance and other receivable | 9,060 | - | - | 9,060 | ||||||||||||||||
| Prepaid expenses and other current assets | 12,154 | - | - | 12,154 | ||||||||||||||||
| TOTAL CURRENT ASSETS | 172,210 | - | 30,000 | 202,210 | ||||||||||||||||
| Property and equipment, net | 2,964 | - | - | 2,964 | ||||||||||||||||
| Intangible assets, net | 472,989 | - | - | 472,989 | ||||||||||||||||
| Other long-term assets | 25,994 | - | - | 25,994 | ||||||||||||||||
| TOTAL ASSETS | $ | 674,157 | $ | - | $ | 30,000 | $ | 704,157 | ||||||||||||
|
LIABILITIES, MEZZANINE EQUITY, AND STOCKHOLDERS' (DEFICIT) EQUITY
|
||||||||||||||||||||
| CURRENT LIABILITIES: | ||||||||||||||||||||
| Accounts payable | $ | 11,672 | $ | - | $ | - | $ | 11,672 | ||||||||||||
| Accrued expenses and other current liabilities | 43,224 | - | - | 43,224 | ||||||||||||||||
| Accrued payroll | 2,773 | - | - | 2,773 | ||||||||||||||||
| Health plan settlements payable | 48,245 | - | - | 48,245 | ||||||||||||||||
| Claims payable | 285,898 | - | - | 285,898 | ||||||||||||||||
| Premium deficiency reserve | 81,402 | - | - | 81,402 | ||||||||||||||||
| Current portion of long-term debt | 51,436 | - | - | 51,436 | ||||||||||||||||
| Short-term debt | 835 | - | - | 835 | ||||||||||||||||
| TOTAL CURRENT LIABILITIES | 525,485 | - | - | 525,485 | ||||||||||||||||
|
Operating lease liability, net
|
10,830 | - | - | 10,830 | ||||||||||||||||
| Warrant liabilities | 2,132 | - | - | 2,132 | ||||||||||||||||
| Long-term debt, net | 259,569 | (195,662) | - | 63,907 | ||||||||||||||||
|
Other long-term liabilities
|
9,308 | - | - | 9,308 | ||||||||||||||||
| TOTAL LIABILITIES | 807,324 | (195,662) | - | 611,662 | ||||||||||||||||
|
COMMITMENTS AND CONTINGENCIES
|
||||||||||||||||||||
| MEZZANINE EQUITY: | ||||||||||||||||||||
| Redeemable non-controlling interest | 10,381 | - | - | 10,381 | ||||||||||||||||
|
STOCKHOLDERS' (DEFICIT) EQUITY:
|
||||||||||||||||||||
| Class A common stock, $0.0001 par value; 800,000 shares authorized; 3,294 shares issued and outstanding as of March 31, 2026 | - | - | - | - | ||||||||||||||||
| Class V common stock, $0.0001 par value; 205,000 shares authorized; 3,919 shares issued and outstanding as of March 31, 2026 | - | - | - | - | ||||||||||||||||
| Series A Preferred Stock | - | 21,293 | - | 21,293 | ||||||||||||||||
| Series B Preferred Stock | - | 18,802 | - | 18,802 | ||||||||||||||||
| Series C Preferred Stock | - | 81,669 | - | 81,669 | ||||||||||||||||
| Series D Preferred Stock | - | - | 30,000 | 30,000 | ||||||||||||||||
| Additional paid in capital | 505,010 | 73,898 | - | 578,908 | ||||||||||||||||
| Accumulated deficit | (649,918) | - | - | (649,918) | ||||||||||||||||
|
Non-controlling interest
|
1,360 | - | - | 1,360 | ||||||||||||||||
|
TOTAL STOCKHOLDERS' (DEFICIT) EQUITY
|
(143,548) | 195,662 | 30,000 | 82,114 | ||||||||||||||||
|
TOTAL LIABILITIES, MEZZANINE EQUITY, AND STOCKHOLDERS' (DEFICIT) EQUITY
|
$ | 674,157 | $ | - | $ | 30,000 | $ | 704,157 | ||||||||||||